BOTHELL, Wash., April 22 /PRNewswire-FirstCall/ -- Helix BioMedix
(HXBM.OB), a developer of synthetic bioactive peptides, today announced that
R. Stephen Beatty, President and Chief Executive Officer, is scheduled to
present an overview of the company at Invest Northwest on April 26, 2005, at
the Bell Harbor Conference Center, Seattle, Washington. Invest Northwest 2005
is hosted by the Washington Biotechnology and Biomedical Association, in
collaboration with BC Biotech, BC MedTech, BioAlberta, Idaho Bioscience
Association, Montana Bioscience Alliance and the Oregon Bioscience Association
Helix BioMedix's presentation at Invest Northwest is scheduled for 11:20
am Pacific Time (8:20 am Eastern Time.) Individuals interested in listening
to the live presentation can participate via webcast at
http://www.helixbiomedix.com or at http://www.wsw.com/webcast/in3/hxbm.ob/. A
replay of the webcast will also be available for 60 days.
About Helix BioMedix
Helix BioMedix, Inc. is an early-stage biotechnology company that has a
portfolio of issued patents that covers six distinct classes of peptides,
covering over 100,000 unique peptide sequences. The company's mission is to
become the industry leader in developing and commercializing small proteins
known as bioactive peptides. The antimicrobial and wound healing properties of
these peptides qualify them for inclusion in a wide range of both
pharmaceutical and consumer products. The company is currently focused on the
development of selected peptides as topical anti-infectives and in wound
healing. Non-pharmaceutical applications being pursued by Helix BioMedix
include adjuvants for cosmetics/cosmeceuticals, personal care, plant health,
animal health and wide-spectrum biocides. More information about the company
and its proprietary peptides can be found on the company's website at
http://www.helixbiomedix.com.
Contact:
Helix BioMedix, Inc.
David Kirske, 425-402-8400
dkirske@helixbiomedix.com
or
Investor Relations:
Cameron Associates
Alison Ziegler, 212-554-5469
alison@cameronassoc.com
SOURCE Helix BioMedix, Inc.
 back to top
Related links:
http://www.helixbiomedix.com
CONTACT:
David Kirske of Helix BioMedix, Inc.,
+1-425-402-8400 or dkirske@helixbiomedix.com; or Investor
Relations: Alison Ziegler of Cameron Associates, +1-212-554-5469
or alison@cameronassoc.com, for Helix BioMedix, Inc.
|
